SMAC-cathepsin B-cleavable peptide-doxorubicin conjugate (KIST)

N/A

Report date: 2025/01/26 16:12:59

Base Information

Drug NameSMAC-cathepsin B-cleavable peptide-doxorubicin conjugate (KIST)
Drug Alias NameSMAC-FRRG-doxorubicinDD-NPs (KIST)SMAC-FRRG-DOX
ClassificationBiologics
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitorsDNA intercalators
TargetsVirus DNA polymeraseTopoisomerase IIDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A